Call our hotline now 1-877-973-4221

Month: February 2010

Catalyst Pharmaceutical Partners And The National Institute On Drug Abuse Plan To Initiate U.S. Phase II(b) Clinical … (Medical News Today)

More info…Catalyst Pharmaceutical Partners, Inc. (NasdaqCM: CPRX) announced that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. …